Australia’s private capital industry grew by 33 per cent in 18 months, reaching A$139 billion
April 01, 2024 17:00 ET
|
Preqin Ltd
The growth of Australia's private capital industry, looking at private equity, venture capital, and private credit. Includes assets under management data
New AI research helps VCs vet ideas 10x faster
March 27, 2024 08:00 ET
|
Vela Partners
Vela Partners and the University of Oxford publish new research about how venture capitalists can use artificial intelligence to vet ideas 10x faster.
LLM Fine-Tuning Startup OpenPipe Raises $6.7 Million
March 26, 2024 08:00 ET
|
OPENPIPE, INC.
SEATTLE, March 26, 2024 (GLOBE NEWSWIRE) -- OpenPipe, a tool that lets developers create their own application-specific Large Language Models (LLMs), today announced the closing of a $6.7 million...
MetasTx LLC Celebrates Dr. David Crich’s Achievement of the 2024 James Flack Norris Award in Physical Organic Chemistry
March 25, 2024 07:48 ET
|
MetasTx LLC
Dr. David Crich, Georgia Research Alliance, and David Chu, Eminent Scholar In Drug Design and Head of Chemistry at MetasTx honored.
SuRo Capital Corp. Tender Offer Expiring on April 1, 2024 at 5:00 P.M., Eastern Time
March 22, 2024 09:00 ET
|
SuRo Capital Corp.
NEW YORK, March 22, 2024 (GLOBE NEWSWIRE) -- SuRo Capital Corp. (“SuRo Capital”, the “Company”, “we”, “us”, and “our”) (Nasdaq: SSSS) today reminded its stockholders its modified “Dutch Auction”...
Eisbach and Cancer Focus Fund Announce $4.5 Million Investment to Support First-in-Human Phase 1/2 Trial of EIS-12656 for Refractory Advanced Solid Tumors
March 21, 2024 07:00 ET
|
Cancer Focus Fund; Eisbach Bio GmbH
Cancer Focus Fund is investing $4.5M for clinical trial of Eisbach's novel approach using synthetic lethality to kill PARP inhibitor resistant tumors
Angelini Ventures invests into extended €75.8 million ($82 million) Series C financing round for Nouscom, a clinical stage immuno-oncology company developing off-the-shelf and personalized cancer vaccines
March 21, 2024 03:00 ET
|
Angelini Ventures
Angelini Ventures joins syndicate of top-tier international healthcare investors in Nouscom’s Series C financing roundFinancing will enable Nouscom to continue advancing the clinical development of...
North America is consolidating alternative assets as region holds almost two-thirds of global AUM – Preqin reports
March 20, 2024 13:26 ET
|
Preqin Ltd
North America is consolidating in alternative assets as region holds almost two-thirds of global AUM – Preqin reports.
CAR-T Funding Report 2024: Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions
March 18, 2024 04:52 ET
|
Research and Markets
Dublin, March 18, 2024 (GLOBE NEWSWIRE) -- The "CAR-T Funding Report - Venture Capital, IPOs, Licensing Deals, Collaborations, and M&A Transactions, 2024" report has been added to ...
SuRo Capital Corp. Reports Fourth Quarter and Fiscal Year 2023 Financial Results
March 13, 2024 16:05 ET
|
SuRo Capital Corp.
Net Asset Value of $7.99 Per Share as of December 31, 2023 Modified Dutch Auction Tender Offer to Repurchase Up To 2 Million Shares Commenced on February 20 ...